Disposable Syringe Markets

Table of Contents

1. Introduction

• 1.1 Statement of Report
• 1.2 About This Report
• 1.3 Scope of the Report
• 1.4 Objectives
• 1.5 Methodology
• 1.6 Executive Summary

2. Disposable Syringe Markets

• 2.1 Overview
• 2.2 Infection Control and Safety
• 2.3 Hospital Consolidations Pressure Companies to Reduce Prices
• 2.4 Needleless Injector Manufacturers Forge Strategic Alliances
• 2.5 Technological Advancements in Disposable Syringes

3. Syringe Market Segments

• 3.1 Overview
  • 3.1.1 World Market
  • 3.1.2 U.S. Market
• 3.2 Total Reusable Needle and Syringe Market
• 3.3 Total Disposable Needle and Syringe Market
  • 3.3.1 Drivers of Safety Syringes
  • 3.3.2 Restraints to Safety Syringes
• 3.4 Pre-filled Syringes
• 3.5 Insulin Injector Pens
• 3.6 Needleless Injectors
• 3.7 Vaccination Injectors
• 3.8 Needle and Syringe Market Trends
  • 3.8.1 Market Segments
  • 3.8.2 Customer Needs
  • 3.8.3 Competitor Analysis
  • 3.8.4 Target Markets for Specialty Syringes
  • 3.8.5 Third Party Reimbursement
  • 3.8.6 Regulation
  • 3.8.7 Drug Discovery Trends
  • 3.8.8 Demographic Shifts
  • 3.8.9 Managed Care Initiatives
  • 3.8.10 Growth in Home Healthcare

4. Technology Development and Sterilization Methods

• 4.1 Disposable Syringes
  • 4.1.1 Autodestruct Syringes
  • 4.1.2 SoloShot™
• 4.2 Monodose Syringes
• 4.3 Pre-filled Syringes
  • 4.3.1 Features of Pre-filled Membrane Syringes
    • 4.3.1.1 Products in Pre-filled Syringes
    • 4.3.1.2 Compatibility of Drug Components
    • 4.3.1.3 Lyophilized Drugs and Powders
    • 4.3.1.4 Dual-chambered Syringes
    • 4.3.1.5 Pre-filled Diluent Syringes
    • 4.3.1.6 Needle Safety Devices for Pre-filled Syringes
    • 4.3.1.7 Sterility Maintenance
  • 4.3.2 Pen Syringes
    • 4.3.2.1 Technical Advances in Pens
    • 4.3.2.2 Advantages of Pens
    • 4.3.2.3 Pen Types and Styles
    • 4.3.2.4 Pre-filled Pens
    • 4.3.2.5 Reusable Pens
    • 4.3.2.6 Device Preparation
    • 4.3.2.7 Autopen
    • 4.3.2.8 Unifine Pentips
  • 4.3.3 Autoject 2
• 4.4 Insulin Syringes
• 4.5 Jet Injectors
• 4.6 Insulin Pens
• 4.7 Uniject™ Injection Device
• 4.8 Microneedle
• 4.9 Needle Free Injection
  • 4.9.1 Hypospray
• 4.10 Glass Pre-fillable Syringes
• 4.11 Retractable Syringe
• 4.12 Ultrasafe Passive Delivery Systems
• 4.13 Ultrasmall Syringes and Microsyringes
• 4.14 Tip Lok® Syringes
• 4.15 Product Profiles
  • 4.15.1 Gettig Guard™
  • 4.15.2 Inviro SNAP! ®
  • 4.15.3 Maxxon Safety Syringe
  • 4.15.4 Monoject Magellan™
  • 4.15.5 Needle-Pro
  • 4.15.6 Point Lok®
  • 4.15.7 SafetyGlide™
• 4.16 SC Injection Technology

5. Business Trends

• 5.1 Market Drivers
• 5.2 Market Prospects
• 5.3 Marketing and Distribution
• 5.4 Competitive Landscape
• 5.5 Business Developments
• 5.6 Acquisitions and Partnerships
• 5.7 Key Players
  • 5.7.1 Kendall
  • 5.7.2 Becton Dickinson
  • 5.7.3 C.R. Bard
  • 5.7.4 International Medication Systems
  • 5.7.5 Terumo Medical Corporation

6. Future Technologies

• 6.1 Thermostable Vaccines and Vaccine Vial Monitors
• 6.2 Sugar Glass
• 6.3 Issues in Technology Transfer for AD Syringes

7. Regulatory Measures

• 7.1 Safety Syringes in Europe
• 7.2 Safety Syringe Regulations and Recommendations
• 7.3 Reimbursement Outlook for Injectables

8. Corporate Profiles

9. Corporate Directory

Appendix 1: FDA Approved Syringe Manufacturers

Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List

Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing

Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act

INDEX OF FIGURES

• Figure 3.1: U.S. Safety Needle and Syringe Market
• Figure 6.1: Strategy of the "Sugar Project"

INDEX OF TABLES

• Table 2.1: Global Market for Needles and Syringes, 2001-2010
• Table 3.1: Global Market for Injection Devices by Category
• Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010
• Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010
• Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010
• Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006
• Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region
• Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006
• Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006
• Table 3.9: Share of Worldwide Safety Syringes Market by Competitor
• Table 3.10: Share of Worldwide Market for Safety Syringes by Region
• Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010
• Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006
• Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor
• Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region
• Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006
• Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005
• Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006
• Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006
• Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region
• Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006
• Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor
• Table 3.22: Summary of Strengths and Weaknesses of Available Syringes
• Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004
• Table 4.1: Injection Data Using Soloshot and Disposable Syringes
• Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes
• Table 4.3: Wastage Analysis (Per Vial Used)
• Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices
• Table 4.5: Region-wise Market of Pre-filled Syringes
• Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006
• Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004
• Table 4.8: Insulin Delivery Systems Percent Retail Market Share
• Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company
• Table 4.10: Commonly-Available Insulin Syringes
• Table 4.11: Features of Available Insulin Pumps
• Table 4.12: Features of Available Jet Injectors
• Table 4.13: Currently Available Insulin Delivery Pens
• Table 4.14: Summary of Clinical and Field Experience with the Uniject Device